🎉 Finosauras is now  SarasRead more
Marksans Pharma Ltd logo

Marksans Pharma Ltd

(NSE: MARKSANS)

Sector: Healthcare

Market Cap: 8,714.339

191.90

+0.69 (0.36%)

CMP

As on 11 Dec 2025, 03:30 pm

Open
190.06
High
193.25
Low
189.01
Close
191.90
Previous Close
191.21

Returns

PeriodReturn %
1 Month2.74
3 Months13.61
1 Year-44.18
5 Years205.26

Last updated on: 04/12/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
ORBIMED ASIA IV MAURITIUS FVCI LIMITED8.62%39,050,881
UTI-HEALTHCARE FUND1.88%8,529,614
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK SPECIAL OPPORTUNITIES FUND1.11%5,027,836

Last updated on: 9/30/2025, 12:00:00 AM

Technical Data

No data available.

Last updated on: 11/12/2025, 3:30 pm

Latest Market News

Fundamental Data

Fundamental Analysis

P/E Ratio

36.17

P/B Ratio

5.83

PEG Ratio

1.31

ROE

14.45%

EPS

5.32

Dividend Yield

0.42%

Market Cap

8,714.339

Sector

N/A

Last Updated: 10 Dec 2025, 02:30 pm

Loading peer comparison...

About : Marksans Pharma Ltd.

Incorporated Year

1992

City and State

Mumbai, Maharashtra

Listing Date

Director's Name

Shailaja Vardhan

Revenue

1178.57 Cr

Net Profit

188.27 Cr

FAQs